21 November 2017
News and Views
Links and Services
HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients, finds the most recent issue of the Journal of Clinical Gastroenterology.
Dr Wei Liu and colleagues evaluated the HER-2/neu protein level by immunohistoch
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors